iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products.
Hastedt JE, Bäckman P, Cabal A, Clark A, Ehrhardt C, Forbes B, Hickey AJ, Hochhaus G, Jiang W, Kassinos S, Kuehl PJ, Prime D, Son YJ, Teague S, Tehler U, Wylie J.
Hastedt JE, et al. Among authors: prime d.
Mol Pharm. 2024 Jan 1;21(1):164-172. doi: 10.1021/acs.molpharmaceut.3c00685. Epub 2023 Dec 7.
Mol Pharm. 2024.
PMID: 38059771
Free PMC article.